Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic Dysfunction-associated Steatohepatitis”

161 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 161 results

Not applicableLooking for participantsNCT06813508
What this trial is testing

Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseHepatocellular CarcinomaMetabolic Dysfunction-Associated Steatohepatitis+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06588699
What this trial is testing

Digoxin In NASH (CODIN)

Who this might be right for
NASHNAFLDMASH - Metabolic Dysfunction-Associated Steatohepatitis+5 more
Yale University 144
Testing effectiveness (Phase 2)Looking for participantsNCT06920043
What this trial is testing

Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis
Boston Pharmaceuticals 42
Not applicableLooking for participantsNCT07294963
What this trial is testing

Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNeurocognitive Disorders
Khyber Medical University Peshawar 45
Not applicableNot Yet RecruitingNCT06453239
What this trial is testing

Assessment the Diagnostic Value of Pro-Neurotensin as a Serum Biomarker in MASLD

Who this might be right for
Steatosis of Liver
Sohag University 80
Post-approval studies (Phase 4)Looking for participantsNCT06523530
What this trial is testing

Effect of a GnRH Analog on Hepatic Steatosis

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty LiverEndometriosis
Aristotle University Of Thessaloniki 62
Post-approval studies (Phase 4)Study completedNCT03646292
What this trial is testing

Antidiabetic Drugs for Steatotic Liver Disease

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 DiabetesDigestive System Disease+11 more
Yonsei University 51
Not applicableNot Yet RecruitingNCT07412444
What this trial is testing

EVOO and Metabolic Liver Health in MASLD

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseOverweight
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 60
Not applicableStudy completedNCT05778266
What this trial is testing

Effect of L-citrulline and HIIT on Arterial Stiffness, Body Composition, and Lipid Profile in Adolescents with Steatosis Associated with Metabolic Dysfunction (MASLD)

Who this might be right for
Metabolic Dysfunction-Associated Fatty Liver DiseaseObesity, AdolescentArterial Stiffness
Universidad de Guanajuato 43
Testing effectiveness (Phase 2)Looking for participantsNCT07145151
What this trial is testing

UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis (MASH)
The United Bio-Technology (Hengqin) Co., Ltd. 156
Not applicableLooking for participantsNCT07270601
What this trial is testing

Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseNAFLD - Non-Alcoholic Fatty Liver Disease
ContextVision AB 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT06465186
What this trial is testing

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

Who this might be right for
Non-alcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisNAFLD+2 more
Merck Sharp & Dohme LLC 80
Post-approval studies (Phase 4)Looking for participantsNCT07249788
What this trial is testing

Resmiterom Efficacy & Safety in Patients With MASH

Who this might be right for
MASH - Metabolic Dysfunction-Associated Steatohepatitis
Nabiqasim Industries (Pvt) Ltd 165
Large-scale testing (Phase 3)Looking for participantsNCT06461208
What this trial is testing

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
King's College London 300
Not applicableLooking for participantsNCT07083336
What this trial is testing

Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)

Who this might be right for
Type 2 Diabetes MellitusMetabolic Dysfunction-associated Steatotic Liver Disease
State Key Laboratory of Subhealth Intervention Technology 120
Not applicableNot Yet RecruitingNCT07241195
What this trial is testing

A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes

Who this might be right for
NAFLD and NASHNAFLD( Non-alcoholic Fatty Liver Disease )NAFLD Cirrhosis
The Affiliated Hospital of Hangzhou Normal University 20,000
Testing effectiveness (Phase 2)Study completedNCT06342947
What this trial is testing

ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)

Who this might be right for
NASHMASHMetabolic Dysfunction-Associated Steatohepatitis+1 more
Aligos Therapeutics 102
Early research (Phase 1)Looking for participantsNCT07334080
What this trial is testing

ECC4703 Food Effect and Relative Bioavailability Study in Healthy Adult Participants

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis
Eccogene 72
Not applicableNot Yet RecruitingNCT07332611
What this trial is testing

Long Term Prediction of MASH-related HCC Risk by Proteomics

Who this might be right for
MASH-related HCC
University Hospital, Bordeaux 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07193927
What this trial is testing

Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseFatty Liver Disease, NonalcoholicOverweight (BMI > 25)
AB Biotics, SA 60
Load More Results